Trials / Unknown
UnknownNCT04257786
Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer
Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) Followed by Surgery in Patients With Advanced Primary Epithelial Ovarian Cancer: A Pilot Randomized Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Assessment of efficacy of primary cyto-reductive surgery in patients with advanced primary epithelial ovarian cancer in Comparison to patients receiving neo-adjuvant chemotherapy (NAC) followed by surgery in complete excision of the tumor reaching R0 without significant morbidity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 1ry cyto-reductive surgery | 1ry surgery then chemotherapy |
| COMBINATION_PRODUCT | Neoadjuvant chemotherapy followed by surgery | chemotherapy then surgery |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2021-12-30
- Completion
- 2022-04-01
- First posted
- 2020-02-06
- Last updated
- 2020-02-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04257786. Inclusion in this directory is not an endorsement.